Ir para o conteúdo principal

United States News Todas as matérias

Todas as matérias desta seção, das mais recentes às mais antigas — página 257 de 371.

Grafa
Health

Citius Oncology reports positive Phase 1 data for LYMPHIR-Pembrolizumab combo

Citius Oncology (NASDAQ:CTOR) reported positive topline results on Tuesday from an investigator-initiated Phase 1 clinical trial evaluating its flagship immunotherapy, LYMPHIR (denileukin diftitox-cxdl), in combination with Merck’s pembrolizumab (Keytruda).

Leia mais: Citius Oncology reports positive Phase 1 data for LYMPHIR-Pembrolizumab combo
Grafa
Technology

Anthropic warns of ‘billions’ in lost revenue over Pentagon security blacklist

Anthropic PBC warned a federal judge on Tuesday that it faces the potential loss of billions of dollars in revenue this year due to the Trump administration’s decision to label the artificial intelligence startup a national security risk.

Leia mais: Anthropic warns of ‘billions’ in lost revenue over Pentagon security blacklist
Grafa
Technology

Interactive Strength finalizes Ergatta deal, boosts 2026 revenue outlook to $30M

Interactive Strength (NASDAQ:TRNR) has finalized its acquisition of Ergatta, a leading provider of gamified connected rowing equipment, marking a significant expansion of its fitness technology portfolio. In conjunction with the closing, the company raised its 2026 pro forma revenue guidance to more than $30 million, reflecting the immediate scale provided by the merger.

Leia mais: Interactive Strength finalizes Ergatta deal, boosts 2026 revenue outlook to $30M